Home » Trials » SLCTR/2025/030
Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI): A Randomized Clinical Trial
-
SLCTR Registration Number
SLCTR/2025/030
Date of Registration
The date of last modification
Aug 20, 2025
Scientific Title of Trial
Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI): A Randomized Clinical Trial
Public Title of Trial
Randomized clinical trial to assess the effectiveness and the safety of single versus double stitch laparoscopic procedure (Burch Colposuspension) for women with Stress Urinary Incontinence
Disease or Health Condition(s) Studied
Stress urinary incontinence
Scientific Acronym
None
Public Acronym
None
Brief title
Evaluation of One-Stitch Versus Two-Stitch Laparoscopic Burch Colposuspension for Stress Urinary Incontinence (SUI)
Universal Trial Number
U1111-1320-9390
Any other number(s) assigned to the trial and issuing authority
Ref No: P/26/03/2025 ERC obtained from Faculty of Medicine, University of Kelaniya
What is the research question being addressed?
What is the efficacy and safety of one-stitch versus two-stitch laparoscopic Burch colposuspension in the surgical management of stress urinary incontinence (SUI)?
Type of study
Interventional
Study design
Allocation
Randomized controlled trial
Masking
Single blinded : Participants, Data analysts, Outcome assessors
Control
Standard therapy/practice
Assignment
Parallel
Purpose
Treatment
Study Phase
Not Applicable
Intervention(s) planned
Study Setting(s) The study will be conducted at the following locations: • Primary site: Professorial Gynaecology Unit, Colombo North Teaching Hospital (CNTH), Ragama. • Secondary sites: Gynaecological theatres and clinics at Hemas Hospital (Pvt) Ltd, Wattala, and Leesons Hospital (Pvt) Ltd, Ragama. Patient recruitment will occur through gynaecology outpatient clinics, patient assessment rooms, theatre admissions, and inpatient wards of the aforementioned hospitals.
Randomization a. Method of Randomization into Study Arms • Block randomization will be used to ensure balance between the two arms throughout the study period. • Block size: A block size of 4 will be used to maintain equal distribution in each group. b. Unit of Randomization • The individual patient is the unit of randomization. c. Method of Sequence Generation • A computer-generated random sequence will be used to assign participants to either the one-stitch or two-stitch surgical group in a 1:1 ratio. d. Method of Allocation Concealment • Allocation will be concealed using sequentially numbered, sealed, opaque envelopes (SNOSE technique), prepared by an independent researcher not involved in the clinical care or outcome assessment.
Intervention Details Intervention: • Surgical Procedure: Laparoscopic Burch colposuspension. Technique: • In the one-stitch group, a single non-absorbable No. 1.0 black silk suture will be placed bilaterally at the mid-urethral level and anchored to Cooper’s ligament. • In the two-stitch group, two non-absorbable No. 1.0 black silk sutures will be placed bilaterally—one at the mid-urethral level and one at the bladder neck level—and both anchored to Cooper’s ligament. Standardization: • All procedures will follow a standardized laparoscopic technique. • Patients will undergo general anaesthesia. • Operative and perioperative care (including pain management and catheterization) will be uniformly provided for both groups. Who Performs the Intervention: • All surgeries will be performed by experienced laparoscopic gynaecological surgeons affiliated with the study institutions, ensuring surgical consistency and technical expertise.
Blinding Blinding procedures implemented in this RCT include: • Participants will not be informed of the specific surgical technique used. • Healthcare providers (surgeons) cannot be blinded due to the nature of the surgical intervention. • Data collectors and outcome adjudicators will remain blinded during follow-up assessments and data recording to minimize observer bias. • Data analysts will analyze de-identified data without knowledge of group assignments.
Inclusion criteria
• Adult women clinically diagnosed with stress urinary incontinence (SUI). • Consented for laparoscopic Burch colposuspension. • No prior surgical treatment for SUI. • Aged 30-70 years
Exclusion criteria
• Presence of urge incontinence or mixed incontinence with urge symptoms as the dominant component. • History of recurrent SUI, or grade >2 pelvic organ prolapse. • Contraindications to general anesthesia or laparoscopic surgery (e.g., severe obesity, significant comorbidities).
Primary outcome(s)
1.
Objective continence success: Absence of urinary leakage during a standardized pad test |
[ 6 and 12 months post-surgery. ] |
Secondary outcome(s)
1.
Subjective continence success using a questionnaire |
[ at 6 weeks,6 and 12 moths post-surgery ] |
2.
Operative time (minutes). |
[ during the surgey ] |
3.
Early post-operative complications of laparoscopic Burch colposuspension. Retropubic bleeding/hematoma → tachycardia, falling Hb, suprapubic mass · Urinary retention/incomplete emptying (from over-elevation/edema) · Port-site issues: bleeding, infection; rarely early hernia · Ileus; unrecognized bowel/urinary tract injury presenting late with peritonitis or hematuria |
[ During surgery –2 weeks ] |
4.
Intermediate Post-operative complications of laparoscopic Burch colposuspension De novo urgency/urge incontinence (detrusor overactivity) · Voiding dysfunction/obstructive symptoms, high post-void residuals · Suture-related problems: intravesical/urethral suture → irritative LUTS, hematuria, calculus · Retropubic abscess or infected hematoma · Pelvic/suprapubic pain; neuropathic groin pain (ilioinguinal/genitofemoral entrapment) · Dyspareunia Late · Recurrent stress urinary incontinence (failure of suspension) |
[ 2 weeks –12 weeks ] |
5.
Chronic post operative complications of Burch Coloposuspension Urinary retention/obstruction · Bladder/urethral erosion or, very rarely, fistula |
[ After 2 weeks ] |
6.
Patient satisfaction and quality-of-life improvement (measured using validated scales such as the International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form [ICIQ- UI SF]). |
[ At 6 and 12 months post surgery ] |
Target number/sample size
144 (72 per each group)
Countries of recruitment
Sri Lanka
Anticipated start date
2025-10-01
Anticipated end date
2027-12-31
Date of first enrollment
Date of study completion
Recruitment status
Pending
Funding source
Pending
Regulatory approvals
Sri lanka clinical trial registry
Status
Approved
Date of Approval
2025-05-14
Approval number
P/26/03/2025
Details of Ethics Review Committee
Name: | Ethics Review Committee of the Faculty of Medicine, University of Kelaniya |
Institutional Address: | Faculty of Medicine, University of Kelaniya |
Telephone: | 0112961000 |
Email: | info.med@kln.ac.lk |
Contact person for Scientific Queries/Principal Investigator
Dr.Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya
0775404921
prabathrandombage@gmail.com
Contact Person for Public Queries
Dr.Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya
0775404921
prabathrandombage@gmail.com
Primary study sponsor/organization
Dr. Prabath Randombage
Senior Lecturer (Grade II) Department of Obstetrics & Gynaecology
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya
+94 775404921
prabathrandombagera@gmail.com
Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?
No
IPD sharing plan description
Study protocol available
No
Protocol version and date
Not Available
Protocol URL
Not Available
Results summary available
No
Date of posting results
Date of study completion
Final sample size
Date of first publication
Link to results
Brief summary of results